Skip to Main Content

Paper Details

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.
AJR Am J Roentgenol
6
2018
Author NameAffiliation
Christoph I LeeUniversity of Washington School of Medicine
Christoph I LeeUniversity of California davis
Christoph I LeeUniversity of Illinois at Chicago
Christoph I LeeUniversity of Vermont
Christoph I LeeUniversity of California san francisco
Christoph I LeeBrigham and Women's Hospital, Harvard Medical School, Dana Farber Harvard Cancer Institute, Harvard School of Public Health
Christoph I LeeUniversity of North Carolina
Christoph I LeeMassachusetts General Hospital, Harvard Medical School
Christoph I Lee3 Dartmouth Institute for Health Policy & Clinical Practice, Norris Cotton Cancer Center, Geisel School of Medicine
Christoph I LeeKaiser Permanente Washington Health Research Institute
Ellen MearaUniversity of California davis
Ellen MearaUniversity of Illinois at Chicago
Ellen MearaUniversity of Vermont
Ellen MearaUniversity of California san francisco
Ellen MearaBrigham and Women's Hospital, Harvard Medical School, Dana Farber Harvard Cancer Institute, Harvard School of Public Health
Ellen MearaUniversity of North Carolina
Ellen MearaMassachusetts General Hospital, Harvard Medical School
Ellen Meara3 Dartmouth Institute for Health Policy & Clinical Practice, Norris Cotton Cancer Center, Geisel School of Medicine
Ellen MearaKaiser Permanente Washington Health Research Institute
Ellen MearaUniversity of Washington School of Medicine
Anna N A TostesonUniversity of Washington School of Medicine
Anna N A TostesonKaiser Permanente Washington Health Research Institute
Anna N A Tosteson3 Dartmouth Institute for Health Policy & Clinical Practice, Norris Cotton Cancer Center, Geisel School of Medicine
Anna N A TostesonMassachusetts General Hospital, Harvard Medical School
Anna N A TostesonUniversity of North Carolina
Anna N A TostesonBrigham and Women's Hospital, Harvard Medical School, Dana Farber Harvard Cancer Institute, Harvard School of Public Health
Anna N A TostesonUniversity of California san francisco
Anna N A TostesonUniversity of Vermont
Anna N A TostesonUniversity of Illinois at Chicago
Anna N A TostesonUniversity of California davis
Karen J WernliUniversity of Washington School of Medicine
Karen J WernliKaiser Permanente Washington Health Research Institute
Karen J Wernli3 Dartmouth Institute for Health Policy & Clinical Practice, Norris Cotton Cancer Center, Geisel School of Medicine
Karen J WernliMassachusetts General Hospital, Harvard Medical School
Karen J WernliUniversity of North Carolina
Karen J WernliBrigham and Women's Hospital, Harvard Medical School, Dana Farber Harvard Cancer Institute, Harvard School of Public Health
Karen J WernliUniversity of California san francisco
Karen J WernliUniversity of Vermont
Karen J WernliUniversity of Illinois at Chicago
Karen J WernliUniversity of California davis
Karen J WernliUniversity of Washington School of Medicine
Karen J WernliKaiser Permanente Washington Health Research Institute
Karen J Wernli3 Dartmouth Institute for Health Policy & Clinical Practice, Norris Cotton Cancer Center, Geisel School of Medicine
Karen J WernliMassachusetts General Hospital, Harvard Medical School
Karen J WernliUniversity of North Carolina
Karen J WernliBrigham and Women's Hospital, Harvard Medical School, Dana Farber Harvard Cancer Institute, Harvard School of Public Health
Karen J WernliUniversity of California san francisco
Karen J WernliUniversity of Vermont
Karen J WernliUniversity of Illinois at Chicago
Karen J WernliUniversity of California davis
  • 1 - 50

Datasets